Archive
Year
Volume(Issue)
Issues
Journal Article
Download
فارسی Version
SYD985, a novel duocarmycinbased HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/Neu expression
GYNECOLOGIC ONCOLOGY
Year:
Volume:
Issue:
Pages:
Citations:
Views:
Downloads:
more
View 46